Chinook Therapeutics, Inc.

CIK 1435049 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Chinook Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Nov 22, 2023SC 13D/A0001104659-23-120754
Aug 21, 202315-12G0001193125-23-216824
Aug 16, 2023EFFECT9999999995-23-002403
Aug 11, 2023S-8 POS0001193125-23-210856
Aug 11, 2023S-8 POS0001193125-23-210881
Aug 11, 2023S-8 POS0001193125-23-210849
Aug 11, 2023S-8 POS0001193125-23-210873
Aug 11, 2023S-8 POS0001193125-23-210860
Aug 11, 20238-K0001193125-23-210803
Aug 11, 2023POS AM0001193125-23-210812
Aug 11, 202340001209191-23-045412
Aug 11, 2023S-8 POS0001193125-23-210843
Aug 11, 2023S-8 POS0001193125-23-210877
Aug 11, 2023S-8 POS0001193125-23-210833
Aug 11, 2023S-8 POS0001193125-23-210839
Aug 11, 202340001209191-23-045415
Aug 11, 202340001209191-23-045428
Aug 11, 202340001209191-23-045424
Aug 11, 202340001209191-23-045430
Aug 11, 202340001209191-23-045417
Aug 11, 2023S-8 POS0001193125-23-210869
Aug 11, 202325-NSE0001354457-23-000573
Aug 11, 202340001209191-23-045429
Aug 11, 202340001209191-23-045411
Aug 11, 202340001209191-23-045422